Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (65)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lubrano-Berthelier, C.
Right arrow Articles by Vaisse, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lubrano-Berthelier, C.
Right arrow Articles by Vaisse, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2003, Vol. 12, No. 2 145-153
© 2003 Oxford University Press

Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations

Cecile Lubrano-Berthelier1, Emmanuelle Durand2, Beatrice Dubern1,3, Astrid Shapiro1, Paul Dazin4, Jacques Weill5, Camille Ferron1, Philippe Froguel2,6 and Christian Vaisse1,*

1Diabetes Center and Department of Medicine, University of California, San Francisco, CA 94143, USA, 2CNRS 80-90-Institute of Biology of Lille, Institute Pasteur, Lille, France, 3Pediatric Gastroenterology and Nutrition Department, Armand-Trousseau Teaching Hospital, Paris, France, 4Howard Hughes Medical Institute, 5Department of Pediatrics, Lille University Hospital, Lille, France and 6Barts and The London Genome Center, Queen Mary School of Medicine, London, UK

Received September 17, 2002; Accepted November 13, 2002

Heterozygous mutations in the coding region of the serpentine Melanocortin 4 receptor are the most common genetic cause of human obesity described to date. There are still conflicting data regarding the overall prevalence of such mutations in obesity and limited information is available on the functional defects caused by most obesity-associated MC4R mutations. We report here the screening for mutations in the coding region of the MC4R of a new cohort of 172 patients presenting with severe childhood obesity and a family history of obesity. Three heterozygous MC4R mutations (Ser127Leu, Ala244Glu and Pro299His) were found in three patients of this cohort (1.74%), confirming that such mutations are implicated in a significant number of childhood obesity cases. A functional analysis of these mutant receptors, in addition to 11 other childhood obesity-associated MC4R mutations, indicates that they all alter the activation of the receptor by the endogenous agonist {alpha}-MSH. To further examine the functional defects caused by childhood obesity-associated MC4R mutations, we developed a novel, sensitive technique to quantitatively analyze the effect of a mutation on MC4R cell surface expression. Using this method we analyzed the cell surface expression of all the 14 described childhood obesity-associated MC4R missense mutations. We demonstrate that 81.3% of childhood obesity-associated heterozygous MC4R mutations lead to intracellular retention of the receptor. This result has implications for the potential pharmacologic rescue of childhood obesity-associated MC4R mutations and for the treatment of patients presenting with this condition.

* To whom correspondence should be addressed at: University of California, San Francisco, Diabetes Center and Department of Medicine, Room HSW1113, 513 Parnassus Avenue, San Francisco, CA 94143-0573, USA. Tel: +1 4155140530; Fax: +1 4155645813; Email: vaisse{at}medicine.ucsf.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
M. A. Calton, B. A. Ersoy, S. Zhang, J. P. Kane, M. J. Malloy, C. R. Pullinger, Y. Bromberg, L. A. Pennacchio, R. Dent, R. McPherson, et al.
Association of functionally significant Melanocortin-4 but not Melanocortin-3 receptor mutations with severe adult obesity in a large North American case-control study
Hum. Mol. Genet., March 15, 2009; 18(6): 1140 - 1147.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. Haskell-Luevano, J. W. Schaub, A. Andreasen, K. R. Haskell, M. C. Moore, L. M. Koerper, F. Rouzaud, H. V. Baker, W. J. Millard, G. Walter, et al.
Voluntary exercise prevents the obese and diabetic metabolic syndrome of the melanocortin-4 receptor knockout mouse
FASEB J, February 1, 2009; 23(2): 642 - 655.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
F. Stutzmann, K. Tan, V. Vatin, C. Dina, B. Jouret, J. Tichet, B. Balkau, N. Potoczna, F. Horber, S. O'Rahilly, et al.
Prevalence of Melanocortin-4 Receptor Deficiency in Europeans and Their Age-Dependent Penetrance in Multigenerational Pedigrees
Diabetes, September 1, 2008; 57(9): 2511 - 2518.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Kapur, P. Samaniego, G. A. Thakur, A. Makriyannis, and M. E. Abood
Mapping the Structural Requirements in the CB1 Cannabinoid Receptor Transmembrane Helix II for Signal Transduction
J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 341 - 348.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Hainerova, L. H. Larsen, B. Holst, M. Finkova, V. Hainer, J. Lebl, T. Hansen, and O. Pedersen
Melanocortin 4 Receptor Mutations in Obese Czech Children: Studies of Prevalence, Phenotype Development, Weight Reduction Response, and Functional Analysis
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3689 - 3696.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Liu, J.-P. Fortin, M. Beinborn, and A. S. Kopin
Four Missense Mutations in the Ghrelin Receptor Result in Distinct Pharmacological Abnormalities
J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1036 - 1043.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
I. S. Farooqi and S. O'Rahilly
Genetics of Obesity in Humans
Endocr. Rev., December 1, 2006; 27(7): 710 - 718.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. D. Ahn, B. Dubern, C. Lubrano-Berthelier, K. Clement, and G. Karsenty
Cart Overexpression Is the Only Identifiable Cause of High Bone Mass in Melanocortin 4 Receptor Deficiency
Endocrinology, July 1, 2006; 147(7): 3196 - 3202.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. M. Kublaoui and A. R. Zinn
MC4R Mutations--Weight before Screening!
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1671 - 1672.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Hinney, T. Bettecken, P. Tarnow, H. Brumm, K. Reichwald, P. Lichtner, A. Scherag, T. T. Nguyen, P. Schlumberger, W. Rief, et al.
Prevalence, Spectrum, and Functional Characterization of Melanocortin-4 Receptor Gene Mutations in a Representative Population-Based Sample and Obese Adults from Germany
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1761 - 1769.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Lubrano-Berthelier, B. Dubern, J.-M. Lacorte, F. Picard, A. Shapiro, S. Zhang, S. Bertrais, S. Hercberg, A. Basdevant, K. Clement, et al.
Melanocortin 4 Receptor Mutations in a Large Cohort of Severely Obese Adults: Prevalence, Functional Classification, Genotype-Phenotype Relationship, and Lack of Association with Binge Eating
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1811 - 1818.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. Stanley, K. Wynne, B. McGowan, and S. Bloom
Hormonal Regulation of Food Intake
Physiol Rev, October 1, 2005; 85(4): 1131 - 1158.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y.-X. Tao and D. L. Segaloff
Functional Analyses of Melanocortin-4 Receptor Mutations Identified from Patients with Binge Eating Disorder and Nonobese or Obese Subjects
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5632 - 5638.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
K. A. Beaumont, R. A. Newton, D. J. Smit, J. H. Leonard, J. L. Stow, and R. A. Sturm
Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk
Hum. Mol. Genet., August 1, 2005; 14(15): 2145 - 2154.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
P. Buono, F. Pasanisi, C. Nardelli, L. Ieno, S. Capone, R. Liguori, C. Finelli, G. Oriani, F. Contaldo, and L. Sacchetti
Six Novel Mutations in the Proopiomelanocortin and Melanocortin Receptor 4 Genes in Severely Obese Adults Living in Southern Italy
Clin. Chem., August 1, 2005; 51(8): 1358 - 1364.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
H. Izumi, J. Inoue, S. Yokoi, H. Hosoda, T. Shibata, M. Sunamori, S. Hirohashi, J. Inazawa, and I. Imoto
Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in non-small cell lung cancers
Hum. Mol. Genet., April 15, 2005; 14(8): 997 - 1007.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
I M Heid, C Vollmert, A Hinney, A Doring, F Geller, H Lowel, H-E Wichmann, T Illig, J Hebebrand, F Kronenberg, et al.
Association of the 103I MC4R allele with decreased body mass in 7937 participants of two population based surveys
J. Med. Genet., April 1, 2005; 42(4): e21 - e21.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
K. Wynne, S. Stanley, B. McGowan, and S. Bloom
Appetite control
J. Endocrinol., February 1, 2005; 184(2): 291 - 318.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. H. Larsen, S. M. Echwald, T. I. A. Sorensen, T. Andersen, B. S. Wulff, and O. Pedersen
Prevalence of Mutations and Functional Analyses of Melanocortin 4 Receptor Variants Identified among 750 Men with Juvenile-Onset Obesity
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 219 - 224.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
A. J. Zametkin, C. K. Zoon, H. W. Klein, and S. Munson
Psychiatric Aspects of Child and Adolescent Obesity: A Review of the Past 10 Years
Focus, October 1, 2004; 2(4): 625 - 641.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
L. Ma, P. A. Tataranni, C. Bogardus, and L. J. Baier
Melanocortin 4 Receptor Gene Variation Is Associated With Severe Obesity in Pima Indians
Diabetes, October 1, 2004; 53(10): 2696 - 2699.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
A Dempfle, A Hinney, M Heinzel-Gutenbrunner, M Raab, F Geller, T Gudermann, H Schafer, and J Hebebrand
Large quantitative effect of melanocortin-4 receptor gene mutations on body mass index
J. Med. Genet., October 1, 2004; 41(10): 795 - 800.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y.-X. Tao and D. L. Segaloff
Functional Characterization of Melanocortin-3 Receptor Variants Identify a Loss-of-Function Mutation Involving an Amino Acid Critical for G Protein-Coupled Receptor Activation
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3936 - 3942.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Lubrano-Berthelier, C. Le Stunff, P. Bougneres, and C. Vaisse
A Homozygous Null Mutation Delineates the Role of the Melanocortin-4 Receptor in Humans
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2028 - 2032.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
A. Blondet, M. Doghman, M. Rached, P. Durand, M. Begeot, and D. Naville
Characterization of Cell Lines Stably Expressing Human Normal or Mutated EGFP-Tagged MC4R
J. Biochem., April 1, 2004; 135(4): 541 - 546.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Valli-Jaakola, M. Lipsanen-Nyman, L. Oksanen, A. N. Hollenberg, K. Kontula, C. Bjorbaek, and C. Schalin-Jantti
Identification and Characterization of Melanocortin-4 Receptor Gene Mutations in Morbidly Obese Finnish Children and Adults
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 940 - 945.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. A. Donohoue, Y.-X. Tao, M. Collins, G. S. H. Yeo, S. O'Rahilly, and D. L. Segaloff
Deletion of Codons 88-92 of the Melanocortin-4 Receptor Gene: A Novel Deleterious Mutation in an Obese Female
J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5841 - 5845.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Milligan
Constitutive Activity and Inverse Agonists of G Protein-Coupled Receptors: a Current Perspective
Mol. Pharmacol., December 1, 2003; 64(6): 1271 - 1276.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Lubrano-Berthelier, M. Cavazos, C. Le Stunff, K. Haas, A. Shapiro, S. Zhang, P. Bougneres, and C. Vaisse
The Human MC4R Promoter: Characterization and Role in Obesity
Diabetes, December 1, 2003; 52(12): 2996 - 3000.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y.-X. Tao and D. L. Segaloff
Functional Characterization of Melanocortin-4 Receptor Mutations Associated with Childhood Obesity
Endocrinology, October 1, 2003; 144(10): 4544 - 4551.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Hinney, S. Hohmann, F. Geller, C. Vogel, C. Hess, A.-K. Wermter, B. Brokamp, H. Goldschmidt, W. Siegfried, H. Remschmidt, et al.
Melanocortin-4 Receptor Gene: Case-Control Study and Transmission Disequilibrium Test Confirm that Functionally Relevant Mutations Are Compatible with a Major Gene Effect for Extreme Obesity
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4258 - 4267.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.